Skip to main content
Caplight Logo









Soteria Biotherapeutics

Soteria Biotherapeutics

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://soteriabiotherapeutics.com/

Last Round

Series A

May 17, 2021

Total Funding Raised

$42.3M

Company Overview

Soteria Biotherapeutics is a biotechnology company developing switchable bispecific T-cell engagers designed to treat cancer patients with solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

conditionally active biologicsprotein engineeringbispecific antibodieschemically induced dimerizationCIDimmuno-oncologytargeted protein therapeuticsdrug discoveryswitchable biologicsprecision medicinebiotech platformT-cell engagerstherapeutic windowoff-target toxicitynext-gen biologics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Soteria Biotherapeutics Comparables

Compare Soteria Biotherapeutics with similar companies based on industry and business-model similarity.

Soteria Biotherapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bonum Therapeutics
92%
Tentarix Biotherapeutics
80%
CytomX Therapeutics
79%

Soteria Biotherapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 17, 2021
GrantApr 1, 2019

Soteria Biotherapeutics Investors

Notable investors and investment history

Soteria Biotherapeutics investors
InvestorRounds
Roche Venture FundSeries A
NIH RADxGrant
M VenturesSeries A
5AM VenturesSeries A
Roche Venture FundSeries A
Alexandria Venture InvestmentsSeries A
Alexandria Venture InvestmentsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 9, 2025

    Monthly visitors grew 36% MoM, from 590 to 800.

  • May 17, 2021

    $42M round led by Roche Venture Fund and 5AM Ventures.

Soteria Biotherapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Soteria Biotherapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Soteria Biotherapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range2
Year Founded2018
Last FundingMay 17, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?